These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35884786)

  • 1. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Mena-Vázquez N; Rojas-Gimenez M; Fuego-Varela C; García-Studer A; Perez-Gómez N; Romero-Barco CM; Godoy-Navarrete FJ; Manrique-Arija S; Gandía-Martínez M; Calvo-Gutiérrez J; Morales-Garrido P; Mouriño-Rodriguez C; Castro-Pérez P; Añón-Oñate I; Espildora F; Aguilar-Hurtado MC; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Redondo-Rodriguez R; Velloso-Feijoo ML; Fernández-Nebro A
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study.
    Mena-Vázquez N; Rojas-Gimenez M; Romero-Barco CM; Manrique-Arija S; Francisco E; Aguilar-Hurtado MC; Añón-Oñate I; Pérez-Albaladejo L; Ortega-Castro R; Godoy-Navarrete FJ; Ureña-Garnica I; Velloso-Feijoo ML; Redondo-Rodriguez R; Jimenez-Núñez FG; Panero Lamothe B; Padin-Martín MI; Fernández-Nebro A
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33672699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
    Fernández-Díaz C; Castañeda S; Melero-González RB; Ortiz-Sanjuán F; Juan-Mas A; Carrasco-Cubero C; Casafont-Solé I; Olivé A; Rodríguez-Muguruza S; Almodóvar-González R; Castellanos-Moreira R; Rodríguez-García SC; Aguilera-Cros C; Villa I; Ordóñez-Palau S; Raya-Alvarez E; Morales-Garrido P; Ojeda-García C; Moreno-Ramos MJ; Bonilla Hernán MG; Hernández Rodríguez I; López-Corbeto M; Andreu JL; Jiménez de Aberásturi JRD; Ruibal-Escribano A; Expósito-Molinero R; Pérez-Sandoval T; López-Robles AM; Carreira-Delgado P; Mena-Vázquez N; Urruticoechea-Arana A; Peralta-Ginés C; Arboleya-Rodríguez L; Narváez García FJ; Palma-Sánchez D; Cervantes Pérez EC; Maiz-Alonso O; Alvarez-Rivas MN; Fernández-Melón J; Vela Casasempere P; Cabezas-Rodríguez I; Castellvi-Barranco I; González-Montagut C; Blanco-Madrigal J; Del Val-Del Amo N; Fito MC; Rodríguez-Gómez M; Salgado-Pérez E; García-Magallón B; Hidalgo-Calleja C; López-Sánchez R; Fernández-Aguado S; Fernández-López JC; Castro-Oreiro S; Serrano-García I; García-Valle A; Romero-Yuste S; Expósito-Pérez L; Pérez-Albadalejo L; García-Aparicio A; Quillis-Marti N; Bernal-Vidal JA; Loricera-García J; Hernández JL; González-Gay MA; Blanco R
    Rheumatology (Oxford); 2020 Dec; 59(12):3906-3916. PubMed ID: 33068439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.
    Fernández-Díaz C; Atienza-Mateo B; Castañeda S; Melero-Gonzalez RB; Ortiz-SanJuan F; Loricera J; Casafont-Solé I; Rodríguez-García S; Aguilera-Cros C; Villa-Blanco I; Raya-Alvarez E; Ojeda-García C; Bonilla G; López-Robles A; Arboleya L; Narváez J; Cervantes E; Maiz O; Alvarez-Rivas MN; Cabezas I; Salgado E; Hidalgo-Calleja C; Fernández S; Fernández JC; Ferraz-Amaro I; González-Gay MA; Blanco R;
    Rheumatology (Oxford); 2021 Dec; 61(1):299-308. PubMed ID: 33779697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.
    Cassone G; Manfredi A; Atzeni F; Venerito V; Vacchi C; Picerno V; Furini F; Erre GL; Tomietto P; Fedele AL; Della Casa G; Nucera V; Giannitti C; Salvarani C; Sebastiani M
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
    Mena-Vázquez N; Godoy-Navarrete FJ; Manrique-Arija S; Aguilar-Hurtado MC; Romero-Barco CM; Ureña-Garnica I; Espildora F; Añón-Oñate I; Pérez-Albaladejo L; Gomez-Cano C; Jimenez-Núñez FG; Padin-Martín MI; Fernández-Nebro A
    Clin Rheumatol; 2021 Jan; 40(1):133-142. PubMed ID: 32557255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
    Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F
    Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
    Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Mena-Vázquez N; Godoy-Navarrete FJ; Lisbona-Montañez JM; Redondo-Rodriguez R; Manrique-Arija S; Rioja J; Mucientes A; Ruiz-Limón P; Garcia-Studer A; Ortiz-Márquez F; Oliver-Martos B; Cano-García L; Fernández-Nebro A
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
    Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ
    Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Mena-Vázquez N; Redondo-Rodríguez R; Rojas-Gimenez M; Romero-Barco CM; Manrique-Arija S; Ortega-Castro R; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Espildora F; Aguilar-Hurtado MC; Añón-Oñate I; Pérez-Albaladejo L; Abarca-Costalago M; Ureña-Garnica I; Velloso-Feijoo ML; Irigoyen-Oyarzábal MV; Fernández-Nebro A
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study.
    Manfredi A; Cassone G; Furini F; Gremese E; Venerito V; Atzeni F; Arrigoni E; Della Casa G; Cerri S; Govoni M; Petricca L; Iannone F; Salvarani C; Sebastiani M
    Intern Med J; 2020 Sep; 50(9):1085-1090. PubMed ID: 31661185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease.
    Tardella M; Di Carlo M; Carotti M; Ceccarelli L; Giovagnoni A; Salaffi F
    Inflammopharmacology; 2022 Jun; 30(3):705-712. PubMed ID: 35462572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Predictors of Progression Interstitial Lung Disease in Rheumatoid Arthritis Compared with Other Autoimmune Disease: A Retrospective Cohort Study.
    Mena-Vázquez N; Rojas-Gimenez M; Romero-Barco CM; Manrique-Arija S; Hidalgo Conde A; Arnedo Díez de Los Ríos R; Cabrera César E; Ortega-Castro R; Espildora F; Aguilar-Hurtado MC; Añón-Oñate I; Pérez-Albaladejo L; Abarca-Costalago M; Ureña-Garnica I; Velloso-Feijoo ML; Redondo-Rodriguez R; Fernández-Nebro A
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
    Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
    Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease.
    Brooks R; Baker JF; Yang Y; Roul P; Kerr GS; Reimold AM; Kunkel G; Wysham KD; Singh N; Lazaro D; Monach PA; Poole JA; Ascherman DP; Mikuls TR; England BR
    Rheumatology (Oxford); 2022 Nov; 61(12):4667-4677. PubMed ID: 35377443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China.
    Liu L; Fang C; Sun B; Bao R; Zhang H
    Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.